MEDICA and COMPAMED 2022 Planning Enters Next Stage, Exhibitors Can Still Register
By LabMedica International staff writers Posted on 21 Jul 2022 |

The planning for the world’s leading medical trade fair MEDICA 2022 as well as for COMPAMED 2022, the No. 1 trade fair for suppliers of the medical technology industry, organized by Messe Düsseldorf (Düsseldorf, Germany), has entered the next stage. The current number of exhibitor registrations indicates that participation will surpass last year’s results (MEDICA 2021: 3,033; COMPAMED 2021: 490). Exhibitors can still register online for all segments at MEDICA and COMPAMED which will take place concurrently from November 14 – 17, 2022 at the fairgrounds in Düsseldorf, Germany.
In their globally unique combination, MEDICA 2022 and COMPAMED 2022 will again reflect the entire medical technology value and process chains and present a comprehensive range of medical products, devices and instruments. In 2021, 46,000 trade visitors took part in both events (73% international participation). The focus segments of the MEDICA trade fair are: Laboratory Technology and Diagnostics, Medical Technology and Electromedicine (Imaging and Diagnostics/ Medical Equipment and Devices), Consumer Goods and Consumables, Physiotherapy and Orthopedic Technology, and IT Systems and IT Solutions.
For years, startups from all countries have always participated in MEDICA and COMPAMED in large numbers, both with their own stands and as part of joint stands. The MEDICA START-UP PARK offers an attractive opportunity for participation, especially for first-time exhibitors. In addition to booth presentations, start-ups and scale-ups (companies in the next stage of development) will again provide interesting insights into their current projects in various pitch and presentation formats. For example, the MEDICA DISRUPT sessions, the 11th MEDICA START-UP COMPETITION and the 14th Healthcare Innovation World Cup will all be program highlights at the MEDICA CONNECTED HEALTHCARE FORUM. Overall, about 120 speakers and more than 100 startups will be on hand to discuss digital innovations for mobile and connected healthcare of the future.
Further forums integrated into the individual thematic segments of the trade fair provide a connection to the product innovations and best practices of their application in everyday medical practice. In addition to the MEDICA CONNECTED HEALTHCARE FORUM, these include the MEDICA HEALTH IT FORUM, the MEDICA TECH FORUM, the MEDICA LABMED FORUM and the MEDICA ECON FORUM. The MEDICA conference program also provides a content link to the trend topics of the market and the trade fair. An example is the 45th German Hospital Day, a leading event for the top management of German hospitals, which this year will be held face-to-face again. Two other (English language) conferences will address a mainly international audience: the Conference on Disaster and Military Medicine DiMiMED, and the MEDICA MEDICINE + SPORTS CONFERENCE for the international professional sports medicine and sports science sector.
In order to keep up to date with trends in the preliminary development or manufacturing stages of the medical technology industry, COMPAMED is and remains the must-attend event. This is where supplier companies present a wealth of high-tech and service solutions. Components, microsystems technology, materials processing and coatings, additive manufacturing/ 3D printing, manufacturing technology and machines, packaging and services are key segments that are also reflected by the programs of the two integrated specialist forums: The COMPAMED HIGH-TECH FORUM organized by the IVAM Microtechnology Association and the COMPAMED SUPPLIERS FORUM managed by the trade publication Devicemed. Demand for micro components and processes in the context of digitization and patient-centered diagnostics remains strong since they key to ultra-precise manufacturing and the foundation for lightweight, portable and interconnected devices.
“The medical technology industry right now needs MEDICA and COMPAMED as strong platforms for international exchange, cooperation and business. Because the market is in flux. In certain areas, the pandemic is causing increased demand, for example in point-of-care diagnostics. In addition, companies are seeing an increasing necessity to work jointly with their supply and manufacturing partners to ensure delivery capacity during a time of sharply rising prices and scarce components,” said Christian Grosser, Director Health & Medical Technologies at Messe Düsseldorf. “International networking also helps to open up new markets. You can broaden the base for your own business, while alleviating the effects of obstacles, uncertainties or even sanctions that may apply to certain national markets.”
Related Links:
Messe Düsseldorf
Latest Industry News
- Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
- Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
- New Collaboration to Advance Microbial Identification for Infectious Disease Diagnostics
- Tecan Acquires ELISA Immunoassay Assets from Revvity's Cisbio Bioassays
- Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration
- Philips and Ibex Expand Partnership to Enhance AI-Enabled Pathology Workflows
- Grifols and Inpeco Partner to Deliver Transfusion Medicine ‘Lab of The Future’
- Research Collaboration to Advance AI-Enhanced, Real-Time Optical Imaging in Lung Cancer Biopsy
- CACLP 2025 Unites Global Innovators in IVD Industry
- Bio-Rad to Acquire Digital PCR Developer Stilla Technologies
- ABL Signs Know-How License and Transfer Agreement for Siemens’ Fast Track Diagnostics PCR Portfolio
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
- New Partnership Revolutionizes Analyses of Biological Samples
- Medlab Middle East Looks to The Future of Laboratories
- Medix Biochemica Acquires German Immunoassay Solutions Developer Candor Bioscience
- bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Blood Biomarker Test Could Detect Genetic Predisposition to Alzheimer’s
New medications for Alzheimer’s disease, the most common form of dementia, are now becoming available. These treatments, known as “amyloid antibodies,” work by promoting the removal of small deposits from... Read more
Novel Autoantibody Against DAGLA Discovered in Cerebellitis
Autoimmune cerebellar ataxias are strongly disabling disorders characterized by an impaired ability to coordinate muscle movement. Cerebellar autoantibodies serve as useful biomarkers to support rapid... Read more
Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more
New Error-Corrected Method to Help Detect Cancer from Blood Samples Alone
"Liquid biopsy" technology, which relies on blood tests for early cancer detection and monitoring cancer burden in patients, has the potential to transform cancer care. However, detecting the mutational... Read more
"Metal Detector" Algorithm Hunts Down Vulnerable Tumors
Scientists have developed an algorithm capable of functioning as a "metal detector" to identify vulnerable tumors, marking a significant advancement in personalized cancer treatment. This breakthrough... Read more
Novel Technique Uses ‘Sugar’ Signatures to Identify and Classify Pancreatic Cancer Cell Subtypes
Pancreatic cancer is often asymptomatic in its early stages, making it difficult to detect until it has progressed. Consequently, only 15% of pancreatic cancers are diagnosed early enough to allow for... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more